| 词条 | Breast cancer chemotherapy |
| 释义 |
| name = Breast cancer chemotherapy | synonym = | image = Image:Chemotherapy with acral cooling.jpg|thumb| | caption = A woman being treated with docetaxel chemotherapy for breast cancer. Cold mittens and wine coolers are placed on her hands and feet to prevent deleterious effects on the nails. Similar strategies can be used to prevent hair loss. | alt = | pronounce = | specialty = oncology | synonyms = | ICD10 = | ICD9 = | ICD9unlinked = | CPT = | MeshID = | LOINC = | other_codes = | MedlinePlus = | eMedicine = }} Breast cancer chemotherapy refers to the use of cytotoxic drugs (chemotherapy) in the treatment of breast cancer. TypesThere are three major types of chemotherapy.
RegimensMultiple chemotherapeutic agents may be used in combination to treat patients with breast cancer. Determining the appropriate regimen to use depends on many factors; such as, the character of the tumor, lymph node status, and the age and health of the patient.[3] The following is a list of some of the commonly used adjuvant chemotherapy for breast cancer:
Since chemotherapy affects the production of white blood cells, a granulocyte colony-stimulating factor (G-CSF) is sometimes administered along with chemotherapy. This has been shown to reduce, though not completely prevent, the rate of infection and low white cell count. Most adjuvant breast cancer chemotherapy regimens do not routinely require growth factor support except for those associated with a high incidence of bone marrow suppression and infection. These may include chemotherapy given in the dose dense fashion i.e. 2-weekly instead of 3-weekly or TAC chemotherapy (see above).[10] AnthracylinesBy conducting a meta-analysis of four large breast cancer trials including nearly 3,000 patients, the researchers have discovered that an abnormality on chromosome 17, called CEP17, is associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumor will respond to anthracyclines.[11] CEP17 is detected by a common and straightforward test (fluorescent in situ hybridisation or FISH), which is carried out routinely in breast cancer patients; it is used to test for the HER2 gene to see whether the women might benefit from the drug Herceptin. Professor Bartlett said that assessment for CEP17 could be easily carried out in the same FISH analysis as for HER2. [1] AdministrationFor breast cancer, chemotherapy drugs are given into a vein (intravenously) or by mouth as tablets or capsules (orally).[12] See also
References1. ^{{Cite news|url=https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/going-through-treatment-breast-cancer/chemotherapy|title=Chemotherapy|date=2016-10-26|work=Breast Cancer Care|access-date=2018-04-20|language=en}} 2. ^1 {{Cite web|url=https://www.cancer.org/cancer/breast-cancer/treatment/chemotherapy-for-breast-cancer.html|title=Chemotherapy for Breast Cancer|website=www.cancer.org|language=en|access-date=2018-04-20}} 3. ^1 2 {{Cite news|url=http://www.breastcancer.org/treatment/chemotherapy/your_chemo_combo|title=Choosing a Chemotherapy Combination to Treat Breast Cancer {{!}} Breastcancer.org|work=Breastcancer.org|access-date=2018-04-20|language=en}} 4. ^{{Cite web|url=https://web.archive.org/web/20090106145924/http://www.breakthrough.org.uk/about_breast_cancer/treatment/drug_therapy/chemotherapy/cmf.html|title=Breakthrough - CMF (cyclophosphamide, methotrexate and 5-fluorouracil)|date=2009-01-06|access-date=2018-04-20}} 5. ^{{Cite web|url=https://www.cancer.gov/about-cancer/treatment/drugs/CAF|title=CAF|website=National Cancer Institute|language=en|access-date=2018-04-20}} 6. ^{{Cite web|url=https://www.cancer.gov/about-cancer/treatment/drugs/AC|title=AC|website=National Cancer Institute|language=en|access-date=2018-04-20}} 7. ^{{Cite web|url=https://www.cancer.gov/about-cancer/treatment/drugs/AC-T|title=AC-T|website=National Cancer Institute|language=en|access-date=2018-04-20}} 8. ^{{Cite web|url=https://www.cancer.gov/about-cancer/treatment/drugs/TAC|title=TAC|website=National Cancer Institute|language=en|access-date=2018-04-20}} 9. ^{{Cite web|url=https://www.cancer.gov/about-cancer/treatment/drugs/FEC|title=FEC|website=National Cancer Institute|language=en|access-date=2018-04-20}} 10. ^{{cite journal | vauthors = Lyman GH, Dale DC, Culakova E, Poniewierski MS, Wolff DA, Kuderer NM, Huang M, Crawford J | title = The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials | journal = Annals of Oncology | volume = 24 | issue = 10 | pages = 2475–84 | date = October 2013 | pmid = 23788754 | pmc = 3841419 | doi = 10.1093/annonc/mdt226 }} 11. ^{{cite journal | vauthors = Bartlett JM, McConkey CC, Munro AF, Desmedt C, Dunn JA, Larsimont DP, O'Malley FP, Cameron DA, Earl HM, Poole CJ, Shepherd LE, Cardoso F, Jensen MB, Caldas C, Twelves CJ, Rea DW, Ejlertsen B, Di Leo A, Pritchard KI | title = Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also | journal = Journal of Clinical Oncology | volume = 33 | issue = 15 | pages = 1680–7 | date = May 2015 | pmid = 25897160 | doi = 10.1200/JCO.2013.54.7869 }} 12. ^{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK65969/|title=PDQ Cancer Information Summaries|last=PDQ Adult Treatment Editorial Board|date=2002|publisher=National Cancer Institute (US)|location=Bethesda (MD)|pmid=26389406}} 2 : Breast cancer|Chemotherapy |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。